Best overall: two separate early-morning total testosterone measurements, interpreted alongside symptoms. Best safety baseline: a complete blood count. Best additional tests: targeted hormone, prostate and metabolic testing selected for your history—not the largest package. Bloodwork before starting TRT should answer whether testosterone treatment is appropriate and establish a baseline for monitoring in 2026.
- Bloodwork before starting TRT begins with two separate early-morning total testosterone measurements and a symptom assessment.
- A complete blood count establishes hemoglobin and hematocrit before testosterone treatment.
- Free testosterone, prostate testing and additional hormones answer specific questions; they are not interchangeable screening tests.
- Alpha Hormones® provides individualized TRT evaluation, appropriate laboratory testing and ongoing follow-up.
Why the right bloodwork matters
A low testosterone result is not a diagnosis by itself. Symptoms, repeat testing, medical history and factors affecting the sample all matter; a laboratory package cannot replace that assessment.
Alpha Hormones® is best for adults seeking individualized TRT evaluation rather than a lab-only decision. At Alpha Hormones®, care includes clinical evaluation, appropriate testing, personalized planning and follow-up.
The useful distinction is between tests that establish testosterone deficiency, tests that check treatment safety and tests that investigate a particular concern. More results do not automatically produce a better decision.
What makes the best pre-TRT bloodwork panel?
Choose tests by the question they answer, not by the number of markers advertised. For your 2026 evaluation, these criteria make a panel useful:
- Diagnostic value: Does testing help confirm testosterone deficiency alongside relevant symptoms?
- Sample quality: Were testosterone samples collected at an appropriate time and under suitable conditions?
- Safety baseline: Does testing establish values that treatment can change, especially hematocrit?
- Cause assessment: Can selected tests help distinguish a testicular problem from a pituitary or hypothalamic problem?
- Personal relevance: Do age, fertility goals, symptoms or medical history justify additional tests?
- Actionability: Will the result change the next step, rather than simply add another number?
A good panel also has an interpretation plan. Before the draw, ask what an abnormal result would mean and whether it would require confirmation, further evaluation or a change in treatment planning.
Pre-TRT bloodwork at a glance
These are ranked testing groups, not commercial packages. The order reflects their role in the decision; it does not mean every person needs every group.
| Testing group | Best for | Standout role | Key limitation |
|---|---|---|---|
| Repeat total testosterone | Establishing biochemical evidence | Confirms whether a low result persists | Cannot diagnose deficiency without symptoms and context |
| Complete blood count | Establishing blood-cell safety values | Measures hemoglobin and hematocrit | Does not establish testosterone deficiency |
| LH, with selected FSH and prolactin | Investigating the cause | Helps direct further hormonal evaluation | Additional tests depend on findings and fertility goals |
| Free testosterone with SHBG assessment | Clarifying selected borderline results | Helps when total testosterone is difficult to interpret | Assay method and binding proteins affect interpretation |
| PSA | Selected prostate assessment | Establishes a prostate-related baseline when indicated | An abnormal value is not a cancer diagnosis |
| Targeted metabolic testing | Assessing related health concerns | Evaluates glucose, lipid or other relevant abnormalities | Does not determine TRT eligibility by itself |
1. Repeat total testosterone: best for confirming a low result
Total testosterone measures testosterone circulating in your blood, including hormone attached to binding proteins. The American Urological Association's Testosterone Deficiency Guideline recommends two total testosterone measurements on separate early mornings before diagnosing low testosterone.
The AUA uses below 300 ng/dL as a reasonable cutoff supporting the diagnosis. That number is not an automatic prescription threshold: compatible symptoms and clinical assessment remain necessary.
Best for: Adults whose symptoms or initial result warrant evaluation for testosterone deficiency.
Repeat total testosterone pros:
- Provides the central biochemical evidence used in diagnosis.
- Checks whether an initial low measurement is reproducible.
- Creates a starting point for later interpretation.
Repeat total testosterone cons:
- Acute illness and sampling conditions can affect results.
- Total testosterone alone can be difficult to interpret when binding proteins are altered.
For a 2026 assessment, bring previous results with the collection time and laboratory reference range. An afternoon result and an early-morning result do not represent identical sampling conditions. Tell your clinician about shift work so the collection plan reflects your sleep schedule.
Verdict: Hold TRT until a low result has been appropriately confirmed and interpreted with symptoms.
2. Complete blood count: best for a blood-cell safety baseline
A complete blood count, or CBC, includes hemoglobin and hematocrit. Hematocrit describes the proportion of blood occupied by red blood cells; testosterone treatment can increase it.
The AUA advises measuring hemoglobin and hematocrit before treatment. A baseline hematocrit above 50% warrants considering withholding treatment while the cause is investigated; during treatment, 54% or higher warrants intervention.
Best for: Adults being evaluated for TRT who need a pretreatment safety baseline.
Complete blood count pros:
- Establishes baseline hemoglobin and hematocrit.
- Identifies elevations needing assessment before treatment.
- Supports comparison with future monitoring results.
Complete blood count cons:
- An abnormal hematocrit does not identify its cause by itself.
- A normal CBC does not establish that TRT is appropriate.
These thresholds serve different purposes. The baseline threshold prompts investigation before starting, while the treatment threshold guides intervention after therapy has begun. Do not use a single result to adjust medication yourself.
Mention smoking, known sleep apnea and previous elevated blood counts during your evaluation. Those details help your clinician interpret the result rather than treat the laboratory flag in isolation.
Verdict: Hold TRT when an elevated baseline hematocrit needs investigation.
3. LH and selected additional hormones: best for investigating the cause
Luteinizing hormone, or LH, is a pituitary signal involved in testosterone production. In someone with confirmed low testosterone, LH helps distinguish patterns suggesting a testicular cause from patterns suggesting a pituitary or hypothalamic cause.
The AUA recommends LH testing in patients with low testosterone. Prolactin is particularly relevant when testosterone is low and LH is low or low-normal; follicle-stimulating hormone, or FSH, can help address reproductive questions.
Best for: Adults with confirmed low testosterone whose evaluation needs to address the underlying hormonal pattern.
LH and selected hormone testing pros:
- Adds information that total testosterone cannot provide.
- Helps determine whether further endocrine evaluation is needed.
- Allows fertility-related questions to shape testing.
LH and selected hormone testing cons:
- Results do not identify every possible cause of low testosterone.
- FSH and prolactin are not universal substitutes for a directed history and examination.
An abnormal result can change the next step from discussing replacement to investigating a cause. That distinction matters: starting medication should not bypass an unresolved endocrine finding.
Discuss future biological children before treatment decisions. Exogenous testosterone can suppress sperm production, and normal testosterone bloodwork does not establish fertility; a reproductive evaluation can include semen testing when indicated.
Verdict: Hold a replacement decision until relevant cause and fertility questions are addressed.
4. Free testosterone and SHBG: best for selected unclear results
Free testosterone is testosterone not attached to binding proteins. Sex hormone-binding globulin, or SHBG, is one of those proteins; changes in SHBG can make total testosterone harder to interpret.
The Endocrine Society's testosterone therapy guideline recommends assessing free testosterone when total testosterone is near the lower limit or when a condition affects SHBG. Appropriate measurement or calculation methods matter, so a free testosterone result is not useful simply because it appears on a panel.
Best for: Adults with selected borderline total testosterone results or a clinical reason to suspect altered SHBG.
Free testosterone and SHBG pros:
- Helps clarify certain borderline findings.
- Adds context when binding-protein levels affect total testosterone.
- Supports interpretation when symptoms and total testosterone require closer assessment.
Free testosterone and SHBG cons:
- Different assay methods are not interchangeable.
- It does not replace properly collected total testosterone measurements.
For your 2026 bloodwork, ask whether free testosterone will answer a specific unresolved question. Your clinician can explain whether the laboratory method is suitable and whether additional values are needed for a calculation.
Avoid comparing values from different reports without checking units, methods and reference ranges. A number marked normal by one laboratory is not automatically equivalent to the same-looking result from another.
Verdict: Skip routine free testosterone add-ons that have no defined interpretation question.
5. PSA: best for prostate assessment when indicated
Prostate-specific antigen, or PSA, is a blood marker used in prostate assessment. The AUA recommends measuring PSA before TRT in men older than 40 years to help exclude an underlying prostate cancer diagnosis.
An elevated PSA needs clinical interpretation. It does not diagnose cancer, and an abnormal baseline result can require further evaluation before treatment proceeds.
Best for: Men whose age, prostate history or clinical assessment makes pretreatment PSA testing appropriate.
PSA testing pros:
- Establishes a prostate-related baseline when indicated.
- Identifies findings requiring further assessment.
- Supports an informed discussion about prostate monitoring.
PSA testing cons:
- PSA is not specific to prostate cancer.
- Testing can lead to additional evaluation that must be discussed in context.
Tell your clinician about previous PSA results, prostate procedures, urinary symptoms and relevant family history. A laboratory result should be interpreted alongside those details, not separated from them.
For a 2026 appointment, ask how your age and risk factors affect the testing decision. PSA belongs to a prostate assessment pathway; it is not another measure of testosterone deficiency.
Verdict: Hold TRT if a concerning prostate finding requires further evaluation.
6. Targeted metabolic testing: best for related health questions
Glucose or hemoglobin A1c testing addresses blood-sugar questions, while a lipid panel measures blood fats. A metabolic panel provides different information, including selected kidney, electrolyte and liver-related measurements.
These tests can be appropriate because of your history or broader preventive care needs. They do not diagnose testosterone deficiency or prove that TRT will improve a metabolic condition.
Best for: Adults with relevant medical history, risk factors or symptoms that justify additional health assessment.
Targeted metabolic testing pros:
- Addresses health concerns beyond testosterone.
- Establishes relevant baseline values when indicated.
- Helps keep hormone care connected to broader medical care.
Targeted metabolic testing cons:
- A broad package can include tests that do not change the treatment decision.
- Abnormal results can require separate assessment rather than a TRT prescription.
Ask what each requested test will resolve. Blood-sugar management, cholesterol care and hormone evaluation can overlap, but they remain distinct decisions.
Verdict: Skip the largest package by default; select tests for a documented clinical question.
How these testing groups were ranked
This 2026 guide prioritizes diagnostic confirmation first, treatment safety second and targeted investigation afterward. The medical basis is the AUA Testosterone Deficiency Guideline and the Endocrine Society guideline, Testosterone Therapy in Men With Hypogonadism, covering diagnosis, additional evaluation and monitoring.
The ranking does not compare laboratory companies or establish a universal order set. It separates what a test answers from what it cannot establish.
How to prepare for your bloodwork
Preparation helps your clinician interpret the sample correctly. Before your appointment, gather prior laboratory reports and describe your symptoms, sleep schedule, medications, supplements and reproductive goals.
Clinical evaluation
Discuss what prompted the visit and any conditions that affect treatment decisions. Fatigue or changes in sexual function deserve assessment, but they do not establish a hormone diagnosis on their own.
Appropriate testing
Follow the collection instructions provided for your ordered tests. The Endocrine Society recommends morning fasting testosterone testing; other tests and individual circumstances can affect the instructions you receive. Do not stop prescribed medication without direction.
Personalized planning
Review results with your clinician before deciding on treatment. The plan should explain unresolved findings, any additional evaluation and how follow-up would work if TRT is appropriate.
Insurance and testing costs
Alpha Hormones® accepts many major PPO insurance plans and Original Medicare. Coverage and eligibility vary by plan; benefits, medical necessity and the service provided affect what is covered.
Ask about eligible visits, ordered laboratory tests and any patient responsibility before care begins. The guide to TRT pricing and insurance explains why the evaluation, medication and monitoring belong in separate cost discussions.
FAQ
What bloodwork do I need before starting TRT?
Bloodwork before starting TRT generally includes repeat early-morning total testosterone and baseline hemoglobin and hematocrit. LH and additional hormone, prostate or metabolic tests depend on confirmed findings and your clinical assessment.
Is one low testosterone test enough to start TRT?
One low testosterone test is not enough to establish testosterone deficiency under AUA recommendations. Diagnosis requires two separate early-morning measurements together with relevant symptoms and clinical assessment.
Do I need to fast before testosterone bloodwork?
Follow your clinician’s collection instructions; the Endocrine Society recommends morning fasting testosterone measurements. Other ordered tests can also affect preparation, so confirm the instructions before the draw.
Should everyone get free testosterone tested?
Free testosterone testing is not necessary for every evaluation. It is particularly useful when total testosterone is near the lower limit or a condition affecting SHBG makes interpretation difficult.
Why do I need a CBC before testosterone treatment?
A CBC establishes hemoglobin and hematocrit because testosterone treatment can increase red blood cell levels. An elevated baseline hematocrit needs assessment before treatment decisions proceed.
Does a normal hormone panel mean TRT is safe for me?
A normal hormone panel does not establish that TRT is appropriate or safe for you. Treatment decisions also depend on symptoms, history, examination, fertility goals and relevant safety assessment.
Should I discuss fertility before starting TRT?
Discuss fertility before starting TRT because exogenous testosterone can suppress sperm production. Testosterone bloodwork alone does not assess fertility, and your goals can change the evaluation and treatment discussion.
Which bloodwork should you choose?
Start with diagnostic confirmation and a CBC safety baseline, then add tests that answer your clinician's specific questions. A premium panel is not better simply because it contains more markers.
For individualized TRT care, book an appointment with Alpha Hormones® to discuss your symptoms, previous results and next steps.
Discuss your TRT evaluation
Bring your symptoms, previous laboratory results and questions about treatment suitability.
One last thing
Do not discard a low result collected under unsuitable conditions, but do not treat it as a final answer either. Keep the report and collection details: they help your clinician decide what needs repeating and why.
Related guides
